when is tirzepatide off patent In weight loss battle, Novo and Lilly face growing offensive from licensed copies Mounjaro, Zepbound: Generic GLP-1 Drugs

These include whole cornmeal (not degermed), corn tortillas, plain grits, and cornflakes without added sugar

Bottom line: Its important for anyone interested in switching diabetes medications to consult their healthcare provider about the risks versus benefits

T1D Guide T1D Strong News Personal Stories Resources T1D Misdiagnosis T1D Early Detection Research/Clinical Trials 10 Highlights of the ADA 2025 Standards of Care Glycemic monitoring with CGMs, glucose-lowering agents (GLP-1 receptor agonists), innovative insulin delivery systems, and mental health check-ins are just a few updates to the ADA 2025 Standards of Care

Also showed significant reductions in liver fat (up to 82.4%) and improvements in metabolic parameters Phase 3 (TRIUMPH-4) : The Phase 3 TRIUMPH-4 trial confirmed and exceeded Phase 2 results, demonstrating 28.7% mean weight loss at 68 weeks with the 12 mg dose -- the highest reported for any metabolic peptide in a Phase 3 trial Phase 3 program : Additional Phase 3 trials ongoing for obesity (TRIUMPH-1) and type 2 diabetes (TRANSCEND) MASLD/MASH : Specific trials underway evaluating liver-related endpoints Phase 3 TRIUMPH-4 data have confirmed the Phase 2 promise, though the full Phase 3 program across all indications is still ongoing